TechNavio's analysts forecast the Global Hepatitis C Drugs market to grow at a CAGR of 28 percent over the period 2011'2015. One of the key factors contributing to this market growth is the increasing prevalence of hepatitis C infection. The Global Hepatitis C Drugs market has also been witnessing the shift of treatments from multiple drug therapy to single drug therapy. However, the virus developing resistance to the drugs could pose a challenge to the growth of this market. TechNavio's report, the Global Hepatitis C Drugs Market 2011'2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Hepatitis C Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.Key vendors dominating this market space include GlaxoSmithKline plc, Merck & Co. Inc., Roche Holding Ltd., and Vertex Pharmaceuticals Ltd. Key questions answered in this report: What will the market size be in 2015 and at what rate will it grow'What key trends is this market subject to'What is driving this market'What are the challenges to market growth'Who are the key vendors in this market space'What are the opportunities and threats faced by each of these key vendors'What are the strengths and weaknesses of each of these key vendors'

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Global Hepatitis C Drugs Market 2011-2015
Published on May 2012
Report Summary
TechNavio's analysts forecast the Global Hepatitis C Drugs market to grow at a CAGR of 28 percent over the period 2011'2015. One
of the key factors contributing to this market growth is the increasing prevalence of hepatitis C infection. The Global Hepatitis C Drugs
market has also been witnessing the shift of treatments from multiple drug therapy to single drug therapy. However, the virus
developing resistance to the drugs could pose a challenge to the growth of this market.
TechNavio's report, the Global Hepatitis C Drugs Market 2011'2015, has been prepared based on an in-depth analysis of the market
with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global
Hepatitis C Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key
vendors operating in this market.
Key vendors dominating this market space include GlaxoSmithKline plc, Merck & Co. Inc., Roche Holding Ltd., and Vertex
Pharmaceuticals Ltd.
Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow'
What key trends is this market subject to'
What is driving this market'
What are the challenges to market growth'
Who are the key vendors in this market space'
What are the opportunities and threats faced by each of these key vendors'
What are the strengths and weaknesses of each of these key vendors'
Table of Content
01. Executive Summary
02. Introduction
03. Market Coverage
04. Market Landscape
05. Geographical Segmentation
06. Key Leading Countries
07. Rate of Incidence and Prevalence
08. Vendor Landscape
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
Global Hepatitis C Drugs Market 2011-2015 (From Slideshare) Page 1/4

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
14. Market Trends
15. Key Vendor Analysis
15.1 Roche Holding Ltd.
15.2 Merck & Co. Inc.
15.3 GlaxoSmithKline plc
15.4 Vertex Pharmaceuticals Ltd.
16. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Hepatitis C Drugs Market 2011'2015 (US$ billion)
Exhibit 2: Global Hepatitis C Drugs Market Segmentation by Therapy 2011
Exhibit 3: Global Hepatitis C Drugs Market by Geographical Segmentation 2011
Exhibit 4: Hepatitis C Infection by Source 2011
Exhibit 5: Global Hepatitis C Drugs Market by Vendor Segmentation 2011
Global Hepatitis C Drugs Market 2011-2015 (From Slideshare) Page 2/4

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Global Hepatitis C Drugs Market 2011-2015
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 500.00 Quantity: _____
3 User License--USD 1 700.00 Quantity: _____
5 User License--USD 1 800.00 Quantity: _____
Corporate License--USD 2 500.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Global Hepatitis C Drugs Market 2011-2015 (From Slideshare) Page 3/4

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Global Hepatitis C Drugs Market 2011-2015 (From Slideshare) Page 4/4